1-4 of 4
Lakshmi Sriharsha
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Evaluation of Time-to-Response Parameter as a Predictor of Long-Term Outcomes Following Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia.

Dong Hwan (Dennis) Kim, Jung A. Kim, Jina Yun, Lakshmi Sriharsha, Jun Ho Jang, Kihyun Kim, Chul Won Jung, Suzanne Kamel-Reid, Jerald Radich, Jeffrey H. Lipton
Journal: Blood
Blood (2009) 114 (22): 1110.
https://doi.org/10.1182/blood.V114.22.1110.1110
Published: 2009
Journal Articles

IFN-γ (interferon-gamma) Genotype Predict Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia.

Dong Hwan Dennis Kim, Jee Hyun Kong, Silvia Park, Chul Won Jung, Lakshmi Sriharsha, Wei Xu, Suzanne Kamel-Reid, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Jeffrey H. Lipton
Journal: Blood
Blood (2009) 114 (22): 2178.
https://doi.org/10.1182/blood.V114.22.2178.2178
Published: 2009
Journal Articles

No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.

Dong Hwan (Dennis) Kim, MD, PhD, Lakshmi Sriharsha, Suzanne Kamel-Reid, MD, PhD, Hong Chang, MD, Hans Messner, MD, PhD, Jeffrey Lipton, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1950.
https://doi.org/10.1182/blood.V110.11.1950.1950
Published: 2007
Journal Articles

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Gene Polymorphisms To Predict Response and Resistance to Imatinib Mesylate Therapy in Chronic Myeloid Leukemia.

Dong Hwan (Dennis) Kim, MD, PhD, Lakshmi Sriharsha, Wei Xu, Suzanne Kamel-Reid, Xiangdong Liu, Katherine Siminovitch, Hans Messner, Jeffrey Lipton
Journal: Blood
Blood (2007) 110 (11): 737.
https://doi.org/10.1182/blood.V110.11.737.737
Published: 2007